Skip to main content
SpringerLink
Log in

Clinical pharmacology of amantadine and derivatives

  • Conference paper
Book cover Early Diagnosis and Preventive Therapy in Parkinson’s Disease

Part of the book series: Key Topics in Brain Research ((KEYTOPICS))

Summary

Amantadine has a definite although minor place in the clinical management of parkinsonism. It is simple to administer, well tolerated by patients, with rapid if usually minor to moderate benefit rather than dramatic response, and with few serious adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aoki FY, Stiver HG, Sitar DS, Boudreault A, Ogilvie R (1985) Prophylactic amantadine dose and plasma concentrations—effect relationships in healthy adults. Clin Pharmacol Ther 128: 128–136

    Article  Google Scholar 

  • Borison RL (1983) Amantadine in the management of extrapyramidal side effects. Clin Neuropharmacol 6 [Suppl] 1: S 57–63

    Article  Google Scholar 

  • Dallos V, Heathfield K, Stone P (1972) Use of amantadine in Parkinson’s disease. Result of a double-blind trial. Br Med J. 4: 24–26

    Article  Google Scholar 

  • Fasano VA, Urciuoli R, Broggi G (1970) Primo osservazioni sull’uso dell’amantadina per via endovenosa e dulla associazione dell’amantadina per via orale con farmaci anticolinergici e con levo-dopa nel trattamento della malattia di Parkinson. Minerva Med 61: 2895

    PubMed  CAS  Google Scholar 

  • Fünfgeld EW (1970) Amantadin-Wirkung bei Parkinsonismus. Dtsch Med Wochenschr 95: 1834–1836

    Article  PubMed  Google Scholar 

  • Greenburg J (1971) Treatment of parkinsonism with amantadine hydrochloride. Pennsylv Med 74: 54

    Google Scholar 

  • Hayden FG, Hoffman HE, Spyker DA (1983) Differences in side effects of amantadine hydrochloride and Amantadine hydrochloride relative to differences in pharmacokinetics. Antimicrob Agents Chemother 23: 458–464

    PubMed  CAS  Google Scholar 

  • Hunter KR, Stern GM, Laurence DR, Armitage P (1970) Amantadine in parkinsonism. Lancet i: 1127–1129

    Article  Google Scholar 

  • Kelly JT, Abazzahab FS (1971) The antiparkinsonian properties of amantadine in drug-induced parkinsonism. J Clin Pharmacol 11: 211

    CAS  Google Scholar 

  • McEvoy JP (1987) A double-blind crossover comparison of antiparkinsonian drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function. J Clin Psychiatr 48 [Suppl]: 20–23

    Google Scholar 

  • Mann DC, Pearce LA, Waterbury LD (1971) Amantadine for Parkinson’s disease. Neurology 21: 958–962

    PubMed  CAS  Google Scholar 

  • Mindham RHS, Gaind R, Anstree BH, Rimmer L (1972) Comparison of amantadine, orphenadrine and placebo in the control of phenothiazineinduced parkinsonism. Psychol Med 2: 406

    Article  PubMed  CAS  Google Scholar 

  • Parkes JD, Baxter RCH, Curzon G, Knill-Jones RP, Knott PJ, Marsden CD, Tattersall R, Vollum B (1971) Treatment of Parkinson’s disease with amantadine and levodopa. Lancet i: 1083–1085

    Article  Google Scholar 

  • Parkes JD, Baxter RB, Marsden CD, Rees JE (1974) Comparative study of amantadine, benzhexol and levodopa in the treatment of Parkinson’s disease. J Neurol Neurosurg Psychiatr 37: 422–426

    Article  PubMed  CAS  Google Scholar 

  • Parkes JD, Zilkha KJ, Calver DM, Knill-Jones RP (1970) Controlled trial of amantadine hydrochloride in Parkinson’s disease. Lancet i: 259–262

    Article  Google Scholar 

  • Schwab RS, England AC, Poskanzer DC, Young RR (1969) Amantadine in the treatment of Parkinson’s disease. J Am Med Ass 208: 1168

    Article  CAS  Google Scholar 

  • Stetter H (1954) Die Chemie der organischen Ringsbetreme mit Utotropin-Struktur. Angew Chem 66: 217

    Article  CAS  Google Scholar 

  • Timberlake WH, Vance MA (1978) Four-year treatment of patients with parkinsonism using amantadine alone or with levodopa. Ann Neurol 3: 119–128

    Article  PubMed  CAS  Google Scholar 

  • Völler G (1972) Zur Therapie des Parkinson-Syndroms mit Amantadin. Munch Med Wochenschr 14: 1066

    Google Scholar 

  • Webster DD, Sawjer GT (1984) The combined use of amantadine HCI and levodopa/carbidopa in Parkinson’s disease. Curr Ther Res 35: 1010–1013

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Institute of Psychiatry, King’s College School of Medicine and Dentistry, London, UK

    Dr. J. D. Parkes

Authors
  1. Dr. J. D. Parkes
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St. Josef Hospital, University of Bochum, Bochum, Federal Republic of Germany

    Horst Przuntek

  2. Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany

    Peter Riederer

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag/Wien

About this paper

Cite this paper

Parkes, J.D. (1989). Clinical pharmacology of amantadine and derivatives. In: Przuntek, H., Riederer, P. (eds) Early Diagnosis and Preventive Therapy in Parkinson’s Disease. Key Topics in Brain Research. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8994-8_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-8994-8_39

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82080-3

  • Online ISBN: 978-3-7091-8994-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation